Refine by
Sepsis Equipment & Supplies
92 equipment items found
by:Diasorin based inSALUGGIA, ITALY
Sepsis can be difficult to distinguish from other non-infectious conditions in critically ill patients with clinical sign of acute inflammation. However, therapies and outcomes may differ significantly between patients with and without sepsis. Among the potentially available laboratory parameters, Procalcitonin (PCT) has the highest diagnostic accuracy. PCT ...
by:T2 Biosystems, Inc. based inLexington, MASSACHUSETTS (USA)
The T2Bacteria® Panel is the first and only FDA-cleared test to identify sepsis-causing bacteria directly from whole blood without the wait for blood ...
Manufactured by:Inflammatix, Inc. based inBurlingame, CALIFORNIA (USA)
Shooting for the holy grail: Identify the presence, type and severity of an acute ...
Manufactured by:Pepex Biomedical, Inc. based inNorcross, GEORGIA (US) (USA)
According to the Centers for Disease Control and Prevention (CDC), Sepsis is the tenth most common cause of death overall in the U.S. Sadly, there is no commercially available test that actually detects the sepsis bacteria and current clinical protocols are simply a process of ...
by:LightDeck Diagnostics based inBoulder, COLORADO (USA)
We are developing point-of-care, multiplex tests for host-response biomarkers in ...
by:Science in Action based inNess Ziona, ISRAEL
Sepsis is a systemic inflammatory condition associated with the presence of pathogenic microorganisms or their toxins in the blood. Symptoms associated with the presence of circulating endotoxin include fever, hypertension, and, under more extreme cases, endotoxic shock and death. Lipopolysaccharide (LPS) is an endotoxin, an outer membrane component of Gram negative bacteria ...
Manufactured by:Qualigen Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
Since its inception, the Qualigen’s initial R&D focus has been on its FastPack diagnostic system and related core technologies. These same technologies are now the basis for the Company’s expansion into therapeutic applications for the treatment of cancer and infectious disease. Qualigen’s Selective Target Antigen Removal System (STARS), is an investigational therapeutic ...
Manufactured by:Shanghai Fosun Long March Medical Science Co., Ltd based inBaoshan, CHINA
The Pioneer Blood Culture System montiors and detects microbial growth matically to aid in the diagnosis ofbacterial infection such as ...
Manufactured by:Magnolia Medical Technologies based inSeattle, WASHINGTON (USA)
The latest, low-volume Initial Specimen Diversion Device provides you with a reliable contamination-reducing technology for better patient outcomes and decreased cost burdens from a sepsis ...
Manufactured by:Axis-Shield Diagnostics Ltd. based inDundee, UNITED KINGDOM
Sepsis is the body’s systemic inflammatory response to infection and can progress to severe sepsis, septic shock and ultimately multiple organ failure and death. Early diagnosis and appropriate treatment of severe sepsis is vital to improve the patient’s chance of ...
Manufactured by:Proxim Diagnostics Corp. based inSanta Clara, CALIFORNIA (USA)
IL-6 is a marker for severity of COVID-19, sepsis, cytokine release syndrome (CRS), flu, and many other conditions. It is a key mediator of inflammation and an early alarm of various life-threatening events. In case of COVID-19 disease, elevated IL-6 levels predict the high risk of respiratory failure 23 hours in advance. ...
Manufactured by:Response Biomedical Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Procalcitonin (PCT) is a biomarker elevated in the blood of patients suffering from sepsis. Physicians use PCT to distinguish bacterial sepsis from other causes of similar symptoms. RAMP Procalcitonin provides quantitative results in ~15 minutes directly from a small blood sample. When speed, precision and accuracy are critical, the RAMP Procalcitonin test ...
Manufactured by:Admetsys Corporation based inBoston, MASSACHUSETTS (USA)
Cartridge-based design with 4 analytes: blood glucose, lactate, temperature, hematocrit (expandable to 20 analytes), providing up to 7 days of continuous biosensing. Enables early detection and mitigation of sepsis, informs PrecisionOne's glucose regulation ...
Manufactured by:Sepset Biosciences Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Sepset is developing a blood test for hospitals to identify septic patients in the emergency room (ER) and predict those who will have high risk for organ ...
Manufactured by:Biosynex SA based inIllkirch-Graffenstaden, FRANCE
Versatility – Two technologies in a single device for a unique evolutive panel of tests: Tsmart INR. Ksmart SARS-COV2 Antigen. Ksmart SARS-COV2 Antibody. Additional Cardiac, Sepsis and Nutrition parameters coming soon. ...
Manufactured by:Sotera, Inc. based inCarlsbad, CALIFORNIA (USA)
ViSi Mobile? is designed to provide continuous surveillance monitoring for patients in general care settings. Current Monitoring Protocol; ViSi Mobile bridges the gap between intermittent spot checking and ICU intensive monitoring. With continuous surveillance monitoring of key vital signs, early recognition and detection of patient deterioration enables clinicians to make timely and effective ...
Manufactured by:Roche Diagnostics International AG based inRotkreuz, SWITZERLAND
GenMark’s ePlex® Blood-Culture Identification (BCID) Panels provide broad coverage of organisms that can lead to sepsis along with their resistance genes. This broad coverage means that about 95% of currently identified bloodstream infections can be detected early with the ePlex BCID Panels, compared to other panels that detect significantly fewer ...
Manufactured by:Beckman Coulter, Inc. based inBrea, CALIFORNIA (USA)
The benchtop system includes the same automated capabilities and industry-leading 93% first-pass yield of our full-featured DxH 900 hematology analyzer,1 as well as support for the Early Sepsis Indicator (ESId) hematology biomarker for sepsis. Available exclusively for mid-volume laboratories on the DxH 690T, the ESId helps clinicians identify ...
Manufactured by:Bio Fire Diagnostics based inSalt Lake City, UTAH (USA)
Early identification and treatment of sepsis are essential to combat one of the leading causes of hospital patient deaths.1 With 43 targets, the newly expanded and FDA-cleared BioFire® Blood Culture Identification 2 (BCID2) Panel detects pathogens and antimicrobial resistance genes directly from positive blood ...
Manufactured by:N8 Medical, LLC based inPark City, UTAH (USA)
N8 Medical’s initial product will be a ceragenin-eluting CeraShield™ endotracheal tube designed to address a myriad of complications in mechanically-ventilated patients. These patients often develop respiratory infections, which can lead to sepsis and multi-organ failure. ...